PT  - JOURNAL ARTICLE
AU  - Brenda Nyambura Mungai
AU  - Elizabeth Joekes
AU  - Enos Masini
AU  - Angela Obasi
AU  - Veronica Manduku
AU  - Beatrice Mugi
AU  - Jane Onǵanǵo
AU  - Dickson Kirathe
AU  - Richard Kiplimo
AU  - Joseph Sitienei
AU  - Rose Oronje
AU  - Ben Morton
AU  - Stephen Bertel Squire
AU  - Peter MacPherson
TI  - It’s not TB but what could it be? Abnormalities on chest X-rays taken during the Kenya National Tuberculosis Prevalence Survey
AID  - 10.1101/2020.08.19.20177907
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.19.20177907
4099  - http://medrxiv.org/content/early/2020/08/22/2020.08.19.20177907.short
4100  - http://medrxiv.org/content/early/2020/08/22/2020.08.19.20177907.full
AB  - Background The prevalence of diseases other than tuberculosis (TB) detected during chest X-ray (CXR) screening is unknown in sub-Saharan Africa. This represents a missed opportunity for identification and treatment of potentially significant disease. Our aim was to quantify and characterise non-TB abnormalities identified by TB-focused CXR screening during the 2016 Kenya National TB prevalence survey.Methods We reviewed a random sample of 1140 adult (≥15 years) CXRs classified as “abnormal, suggestive of TB” or “abnormal other” during field interpretation from the TB Prevalence Survey. Each image was read (blinded to field classification and study radiologist read) by two expert radiologists, with images classified into one of four major anatomical categories and primary radiological diagnosis. A third reader resolved discrepancies. Prevalence and 95% confidence intervals of abnormalities diagnosis were estimated.Findings Cardiomegaly was the most common non-TB abnormality at 259/1123 (23.1%, 95% CI 20.6%-25.6%), while cardiomegaly with features of cardiac failure occurred in 17/1123 (1.5 %, 95% CI 0.9%-2.4%). We also identified chronic pulmonary pathology including suspected chronic obstructive pulmonary disease in 3.2% (95% CI 2.3%-4.4%) and non-specific patterns in 4.6% (95% CI 3.5%-6.0%). Prevalence of active-TB and severe post-TB lung changes was 3.6% (95% CI 2.6%-4.8%) and 1.4% (95% CI 0.8%-2.3%) respectively.Interpretation Based on radiological diagnosis, we identified a wide variety of non-TB diagnoses during population-based TB screening. TB prevalence surveys and active case finding activities using mass CXR offer an opportunity to integrate disease screening efforts.Funding National Institute for Health Research (IMPALA-grant reference 16/136/35).Evidence before this studyEvidence before this study Tuberculosis (TB) remains the leading adult infectious killer in the world. The World Health Organization (WHO) recommends the use of chest X-ray (CXR) as a mass screening tool in TB prevalence surveys and active case finding activities to identify patients eligible for bacteriological investigation. Mathematical modelling suggests that an algorithm incorporating a screening CXR to direct subsequent Xpert MTB/RIF testing is the optimal pathway with lowest number needed to test at acceptable programme costs in active case finding mass screening activities. Increased digital X-ray availability, coupled with the development of Computer Aided Detection (CAD) software for identification of TB, could enable widespread use of CXR in screening for TB in areas with limited access to radiologists. In addition, CXR has an advantage of detecting conditions besides TB. However, the prevalence of diseases other than TB identified by CXR during TB mass screening or TB prevalence survey activities is unknown.We systematically searched MEDLINE, CINHAL, Global Health and Google scholar databases from 1940–2019 to identify studies that described the prevalence of non-TB CXR findings during TB prevalence surveys or mass screening activities. The WHO Stop TB Department website and reference lists from relevant reviews and studies were used to supplement the search. The search strategy included MESH terms: “Chest Xray” or “Chest-Xray” or “Chest radiograph” or “Mass screening” or “Mass radiography” AND “Tuberculosis screening” or “Tuberculosis triaging” or “TB screening” or “TB triaging” AND “Non-tuberculous” or “Non-TB pathology” or “other pathology”. Our search yielded a number of studies using CXR screening in prevalence surveys as well as active case finding activities. However, studies describing non-TB pathology during mass radiography were few and mostly in the 20th century. A report in Europe between 1946 and 1948 documented 35% non-TB pathology on mass miniature X-rays. Our search did not identify any evidence pertinent to the sub-Saharan African context.Added value of this studyAdded value of this study In this cross-sectional study, we analysed individual-level participant CXR data from the 2016 Kenya National TB Prevalence Survey. Our aim was to quantify and characterise non-TB abnormalities identified by TB-focused CXR screening during the survey. We hypothesised that non-TB abnormalities requiring further clinical review are highly prevalent and need to be considered when implementing CXR screening for TB. Our study identified multiple non-TB diagnoses. The most prevalent was cardiomegaly at 23.1% (95% CI 20.6%-25.6%). We also identified chronic pulmonary pathology including suspected chronic obstructive pulmonary disease (COPD) and non-specific interstitial patterns. Mediastinal masses, excluding goitres, occurred in 0.8% (95% CI 0.4%-1.5%). TB related abnormalities, which may cause chronic respiratory symptoms, such as severe bronchiectasis and/or destroyed lung were present in 1.4%(95% CI 0.8%-2.3%). Median CAD4TB scores were low for the non-TB abnormalities.Implications of all the available evidenceImplications of all the available evidence Our study demonstrated a high prevalence of CXR-identified non-TB abnormalities, including cardiomegaly, chronic pulmonary diseases, post-TB lung disease and non-specific lung diseases. Implementation of CXR TB screening in this context requires detailed health system planning to incorporate provision of care to people with non-TB abnormalities. This could include incorporation of additional tests such as blood pressure monitoring and spirometry as part of community TB screening interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the National Institute for Health Research (NIHR) (IMPALA, grant reference 16/136/35) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted as part of the Kenya Prevalence survey ethics approval reference number SSC 2094 by Kenya Medical Research Institute.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe Kenya Division of National Tuberculosis, Leprosy and Lung Disease program is the custodian of the 2016 Kenya Tuberculosis Prevalence Survey data.